Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Improved Outcomes Software (IOS) was a bioinformatics firm that developed specialized software for the analysis and visualization of genomic data. Its primary product, GeneSight, provided researchers with tools for clustering, data mining, and statistical analysis of microarray experiments. Based in Kingston, Ontario, the company served academic and commercial laboratories seeking to interpret large-scale gene expression datasets. In 2004, the GeneSight product line was acquired by BioDiscovery, Inc., which integrated the technology into its own suite of genomic analysis solutions. IOS played a significant role in the early 2000s bioinformatics landscape by simplifying the complexity of high-throughput biological data. The company's software was known for its user-friendly interface and robust algorithmic foundation, making advanced genomic analysis accessible to biologists.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Improved Outcomes Software.